Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of selective enzyme inhibitors and receptor antagonists. Its structure supports conjugation in prodrug designs, where the nitrobenzyl group acts as a photolabile or metabolically cleavable protecting group. Commonly employed in medicinal chemistry for creating targeted drug delivery systems and in the preparation of bioactive molecules with improved stability and specificity.